CRISPR Therapeutics AG

Ownership Transactions Reported by 21 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	4	-163 K	100%	$67.59	-$11 M
Net	-4	-163 K	-100%		-$11 M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Simeon George	Director	$55 M			May 30, 2024
Rodger Novak	President, Director	$35.8 M			Jun 30, 2021
Samarth Kulkarni	Chief Executive Officer, Director	$24.7 M	-$10.1 M	-29.1%	Apr 15, 2024
James R. Kasinger	General Counsel and Secretary	$4.55 M	-$457 K	-9.12%	Mar 20, 2024
Tony W. Ho	Executive VP, Head of R&D	$3.27 M			Dec 3, 2021
Julianne Bruno	Chief Operating Officer	$776 K	-$189 K	-19.6%	Jun 20, 2024
Raju Prasad	Chief Financial Officer	$471 K	-$256 K	-35.2%	Mar 20, 2024
Brendan Smith	Chief Financial Officer	$317 K			Feb 18, 2023
Phuong Khanh Morrow	Chief Medical Officer	$276 K			Oct 13, 2023
Michael John Tomsicek	Chief Financial Officer	$118 K			Aug 6, 2021
Lawrence Otto Klein	Cbo & Coo				Aug 16, 2022
Katherine A. High	Director				May 30, 2024
Christian Rommel	Director				May 30, 2024
Sandesh Mahatme	Director				May 30, 2024
Ali Behbahani	Director				May 30, 2024
Bradley J. Bolzon PhD	Director				Jun 9, 2022
John Greene	Director				May 30, 2024
Maria Fardis	Director				May 30, 2024
Naimish Patel	Chief Medical Officer				May 28, 2024
Harold Edward Fleming	Director				May 30, 2024
Douglas A. Treco	Director				May 30, 2024

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership